Table 2.
CpG | chr | position | Gene Symbol | Gene Group | Less than 1 per week | Less than 1 per day | 1–5 per day | 6–10 per day | 11–20 per day | More than 20 per day | F | P-Value | Adjusted P-Value | EWAS catalogue (same direction/total studies) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cg05575921 | chr5 | 373378 | AHRR | Body | −0.028 | −0.054 | −0.097 | −0.216 | −0.183 | −0.217 | 208.2 | 1.3E–226 | 9.7E–221 | 26/26 |
cg21566642 | chr2 | 233284661 | −0.030 | −0.058 | −0.066 | −0.109 | −0.111 | −0.160 | 59.7 | 1.6E–70 | 5.9E–65 | 22/22 | ||
cg01940273 | chr2 | 233284934 | −0.016 | −0.034 | −0.045 | −0.066 | −0.069 | −0.109 | 53.6 | 2.4E–63 | 5.9E–58 | 22/22 | ||
cg03636183 | chr19 | 17000585 | F2RL3 | Body | −0.007 | −0.017 | −0.029 | −0.064 | −0.053 | −0.094 | 50.9 | 2.8E–60 | 5.2E–55 | 21/21 |
ch.6.2768623F | chr6 | 144037285 | PHACTR2 | Body | −0.002 | −0.001 | 0.000 | 0.009 | −0.005 | 0.350 | 49.1 | 4.7E–58 | 7.0E–53 | Not reported |
cg21161138 | chr5 | 399360 | AHRR | Body | −0.008 | −0.016 | −0.015 | −0.071 | −0.043 | −0.069 | 40.6 | 5.7E–48 | 7.1E–43 | 16/16 |
cg17739917 | chr17 | 38477572 | RARA | 5‘UTR | −0.008 | −0.053 | −0.034 | −0.069 | −0.082 | −0.116 | 38.2 | 4.5E–45 | 4.8E–40 | 7/7 |
cg15928392 | chr2 | 81694446 | 0.000 | 0.000 | 0.001 | −0.001 | −0.002 | −0.106 | 34.1 | 3.4E–40 | 3.2E–35 | Not reported | ||
cg16774290 | chr7 | 4824628 | AP5Z1 | Body | 0.000 | 0.000 | 0.000 | −0.001 | 0.000 | −0.100 | 33.2 | 4.1E–39 | 3.4E–34 | Not reported |
cg11173636 | chr10 | 65632259 | −0.008 | 0.017 | 0.024 | 0.018 | 0.339 | −0.020 | 30.5 | 8.5E–36 | 6.3E–31 | Not reported | ||
cg09935388 | chr1 | 92947588 | GFI1 | Body | −0.018 | −0.030 | −0.029 | −0.100 | −0.069 | −0.134 | 30.0 | 3.5E–35 | 2.4E–30 | 20/20 |
cg26703534 | chr5 | 377358 | AHRR | Body | −0.004 | −0.013 | −0.016 | −0.052 | −0.034 | −0.049 | 29.9 | 4.0E–35 | 2.4E–30 | 14/14 |
cg14990808 | chr6 | 28493651 | GPX5 | TSS200 | −0.002 | −0.022 | 0.005 | 0.002 | 0.001 | 0.246 | 26.3 | 1.1E–30 | 6.2E–26 | Not reported |
cg25648203 | chr5 | 395444 | AHRR | Body | −0.006 | −0.005 | −0.011 | −0.047 | −0.037 | −0.057 | 24.8 | 6.2E–29 | 3.3E–24 | 18/18 |
cg04176674 | chr14 | 21121564 | −0.004 | −0.002 | 0.001 | 0.005 | 0.000 | 0.343 | 24.7 | 7.8E–29 | 3.9E–24 | Not reported |
Note: The CpG sites are annotated based on the chromosome (chr), the position (pos), the gene symbol from HGNC, and the gene group (based on the position of the CpG regarding the nearest gene). Each CpG site has a beta value for each consumer group vs non-consumers, a F-statistic (F), a nominal p-value, and an adjusted p-value by Bonferroni. The last column represents the number of studies in the EWAS catalogue that reported the same effect direction compared to the total studies that reported the beta value for the specific CpG site.